Skip to main content

Virchows Archiv

Ausgabe 3/2023

Emerging and provisional B and T-cell lymphoma entities

Inhalt (15 Artikel)

Open Access Editorial

In this issue: Emerging and provisional B and T cell lymphoma entities

Leticia Quintanilla-Martinez

Open Access Review and Perspectives

Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop

Leticia Quintanilla-Martinez, Camille Laurent, Lorinda Soma, Siok-Bian Ng, Fina Climent, Sarah L. Ondrejka, Alberto Zamo, Andrew Wotherspoon, Laurence de Leval, Stefan Dirnhofer, Lorenzo Leoncini

Open Access Review and Perspectives

Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop

Arianna Di Napoli, Lori Soma, Leticia Quintanilla-Martinez, Laurence de Leval, Lorenzo Leoncini, Alberto Zamò, Siok-Bian Ng, Sarah L. Ondrejka, Fina Climent, Andrew Wotherspoon, Stefan Dirnhofer

Open Access Review and Perspectives

The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop

Alberto Zamò, Michiel van den Brand, Fina Climent, Laurence de Leval, Stefan Dirnhofer, Lorenzo Leoncini, Siok-Bian Ng, Sarah L. Ondrejka, Leticia Quintanilla-Martinez, Lorinda Soma, Andrew Wotherspoon

Open Access Review and Perspectives

Cytotoxic peripheral T-cell lymphomas and EBV-positive T/NK-cell lymphoproliferative diseases: emerging concepts, recent advances, and the putative role of clonal hematopoiesis. A report of the 2022 EA4HP/SH lymphoma workshop

Fina Climent, Alina Nicolae, Laurence de Leval, Stefan Dirnhofer, Lorenzo Leoncini, Sarah L. Ondrejka, Lorinda Soma, Andrew Wotherspoon, Alberto Zamo, Leticia Quintanilla-Martinez, Siok-Bian Ng

Open Access Review and Perspectives

Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop

Sarah L Ondrejka, Catalina Amador, Fina Climent, Siok-Bian Ng, Lorinda Soma, Alberto Zamo, Stefan Dirnhofer, Leticia Quintanilla-Martinez, Andrew Wotherspoon, Lorenzo Leoncini, Laurence de Leval

ORIGINAL ARTICLE

Prognostic value and clinicopathological roles of the tumor immune microenvironment in salivary duct carcinoma

Hideaki Hirai, Masato Nakaguro, Yuichiro Tada, Natsuki Saigusa, Daisuke Kawakita, Yoshitaka Honma, Satoshi Kano, Kiyoaki Tsukahara, Hiroyuki Ozawa, Takuro Okada, Kenji Okami, Keisuke Yamazaki, Yukiko Sato, Makoto Urano, Manami Kajiwara, Yoshitaka Utsumi, Tomotaka Shimura, Chihiro Fushimi, Akira Shimizu, Takahito Kondo, Yorihisa Imanishi, Akihiro Sakai, Yuichiro Sato, Takafumi Togashi, Toyoyuki Hanazawa, Takashi Matsuki, Kazuto Yamazaki, Toshitaka Nagao

Original Article

Evaluation of high-risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas

Aanchal Kakkar, Shraddhanjali Satapathy, Kapil Sikka, Pranay Tanwar, SVS Deo, Deepali Jain

Open Access Original Article

Proposal of a grading system for squamous cell carcinoma of the lung — the prognostic importance of tumour budding, single cell invasion, and nuclear diameter

Noémi Zombori-Tóth, Fanni Hegedűs, Szintia Almási, Anita Sejben, László Tiszlavicz, József Furák, Gábor Cserni, Tamás Zombori

ORIGINAL ARTICLE

Clinicopathological characteristics of gastric adenocarcinoma with enteroblastic differentiation and gastric adenocarcinoma with enteroblastic marker expression

Daiki Abe, Yoichi Akazawa, Noboru Yatagai, Takuo Hayashi, Hiroya Ueyama, Shinji Mine, Tetsu Fukunaga, Akihito Nagahara, Takashi Yao, Tsuyoshi Saito

BRIEF REPORT

Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy

Maria G. Mastrosimini, Andrea Mafficini, Luca Tondulli, Michele Milella, Paola Piccoli, Paola Mattiolo, Matteo Fassan, Seung-Mo Hong, Aldo Scarpa, Claudio Luchini

Brief Report

HRAS-mutated primary thyroid malignant melanoma or medullary thyroid carcinoma with melanocytic dedifferentiation? A singular case with an ontogeny–phylogeny quandary

Priyadarsani Subramanian, Anuja Deshmukh, Katha Kante, Asawari Patil, Trupti Pai, Ramandeep Kaur, Swapnil Rane, Omshree Shetty, Suman Kumar Ankathi, Neha Mittal

Open Access Brief Report

Pelvic lymph node dissection for cervical or bladder cancer: embedding residual fat tissue offers no added value

Jasmijn Vaneman, Heleen J. van Beekhuizen, Joost L. Boormans, Patricia C. Ewing-Graham, Geert J. L. H. van Leenders, Ramon G. V. Smolders, H (Lena) C. van Doorn

Open Access Correction

Correction to: Cavity-based lymphomas: challenges and novel concepts. A report of the 2022 EA4HP/SH lymphoma workshop

Arianna Di Napoli, Lori Soma, Leticia Quintanilla‑Martinez, Laurence de Leval, Lorenzo Leoncini, Alberto Zamò, Siok‑Bian Ng, Sarah L. Ondrejka, Fina Climent, Andrew Wotherspoon, Stefan Dirnhofer

Open Access Correction

Correction to: The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop

Alberto Zamò, Michiel van den Brand, Fina Climent, Laurence de Leval, Stefan Dirnhofer, Lorenzo Leoncini, Siok‑Bian Ng, Sarah L. Ondrejka, Leticia Quintanilla‑Martinez, Lorinda Soma, Andrew Wotherspoon

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …